Business Context and Reporting Period
This Form 8-K Current Report is filed by SeaStar Medical Holding Corporation (Nasdaq: ICU) for the reporting period ending July 1, 2025. The filing addresses the Company's compliance status with Nasdaq listing requirements, specifically the Minimum Stockholders' Equity Requirement.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The primary financial metric disclosed is the Minimum Stockholders' Equity Requirement of $2.5 million, which the Company has confirmed it has met as of July 1, 2025.
Material Changes and Listing Status
- Regained Compliance: The Company received confirmation from Nasdaq on July 1, 2025, that it has regained compliance with Nasdaq Listing Rule 5550(b)(1) regarding the $2.5 million minimum stockholders' equity.
- Previous Deficiency: This follows a decision by the Nasdaq Hearings Panel on March 11, 2025, which granted an exception until June 22, 2025, to demonstrate compliance.
- Future Risk: Nasdaq noted that the Company must raise additional funds to maintain compliance, as it is projected to fall below the $2.5 million requirement by the end of July 2025.
Outlook, Risks, and Contingencies
- Mandatory Monitoring: Pursuant to Nasdaq Listing Rule 5815(d)(4)(B), the Company is subject to a Mandatory Panel Monitor until July 1, 2026.
- Strict Consequences for Future Non-Compliance: If the Company falls out of compliance again within the one-year monitoring period, it will not be permitted to submit a plan of compliance or receive additional cure periods. Instead, Nasdaq staff would immediately issue a "Delist Determination Letter."
- Liquidity Contingency: The Company faces an immediate need to raise capital to avoid falling below the equity threshold by the end of July 2025.
Investor Verification Checklist
- Verify the Company's current stockholders' equity balance to confirm it remains above the $2.5 million threshold.
- Monitor for announcements regarding capital raising activities (e.g., equity offerings) intended to sustain compliance through July 2025.
- Review the attached Press Release (Exhibit 99.1) for any additional details on the Company's financial position.
- Track the Company's status under the Mandatory Panel Monitor for the duration of the one-year period ending July 1, 2026.